BVM Capital

BVM Capital is a venture capital investment firm based in Bossier City, Louisiana, with activity across the Southeast United States. It specializes in funding early- and expansion-stage technology-driven companies, including life sciences, biotechnology, and cancer-related platforms, aiming to support scalable products and platforms in large markets. The firm tends to participate in portfolio companies through equity investments and often engages as a lead or co-investor, seeking board representation to guide growth. It targets exits through mergers, acquisitions, or initial public offerings as portfolio companies mature.

Ross Barrett JD

Founder, General Partner

7 past transactions

Embera NeuroTherapeutics

Series A in 2015
Embera NeuroTherapeutics, Inc. is a pharmaceutical company based in Sudbury, Massachusetts, founded in 2005. The company is focused on developing innovative treatments for smoking cessation, cocaine dependence, and other addictions, an area where effective drug therapies are limited or nonexistent. Embera's flagship product, EMB-001, combines the benzodiazepine oxazepam with metyrapone, a cortisol synthesis inhibitor, to target the stress response system and specific brain functions linked to cravings and relapse. This dual-action approach aims to modulate various stress-related pathways, thereby reducing the cravings that drive addictive behaviors. By addressing the underlying mechanisms of addiction, Embera NeuroTherapeutics seeks to offer a more effective solution for individuals struggling with these disorders.

MicroBiome Therapeutics

Seed Round in 2013
MicroBiome Therapeutics, LLC, established in 2009 and headquartered in Broomfield, Colorado, is a biotechnology company specializing in the development of medical foods and pharmaceutical products. The company's core focus lies in creating evidence-based microbiome modulators, designed to selectively alter bacterial populations and their environment within the gastrointestinal tract for treating and preventing serious health conditions. Its flagship product, NM504, comprises a blend of prebiotic ingredients and other naturally occurring compounds formulated to assist diabetic individuals in maintaining healthy blood glucose levels and managing body weight. Formerly known as NuMe Health LLC, MicroBiome Therapeutics aims to harness the power of the gut microbiome for improving overall health status.

K94 Discoveries

Seed Round in 2013
K94 Discoveries, Inc. operates as a biotechnology company and develops anticancer drugs based on discoveries by scientists at LSU’s Pennington Biomedical Research Institute and Feist Weiller Cancer Center. The company is based in the United States.

FIX Health

Seed Round in 2012
FIX Health is a developer of an interactive social media platform that focuses on creating high-quality fitness games. The company aims to make fitness enjoyable and accessible for individuals of all ages and fitness levels by combining exercise, gaming, and social connectivity. Through its innovative platform, FIX Health promotes health and daily activity in a fun and engaging manner, encouraging users to pursue an active lifestyle while fostering a hyper-social environment.

NuMe Health

Series A in 2012
NuMe Health is a biotechnology company focused on medical foods for the special dietary requirements associated with major chronic diseases including: cancer, obesity, and diabetes.

NuMe Health

Series A in 2011
NuMe Health is a biotechnology company focused on medical foods for the special dietary requirements associated with major chronic diseases including: cancer, obesity, and diabetes.

Calosyn Pharma

Seed Round in 2009
Calosyn Pharma specializes in developing innovative treatments for osteoarthritis. Its flagship product, CAL-05CR, is a sustained-release injectable therapy combining verapamil with a biodegradable delivery system. This treatment aims to provide long-lasting pain relief and reduce inflammation by targeting the underlying causes of osteoarthritis.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.